UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051598
Receipt number R000058836
Scientific Title Relationship between 5-aminolevulinic acid and iron metabolism
Date of disclosure of the study information 2023/07/14
Last modified on 2026/02/09 11:42:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between 5-aminolevulinic acid and iron metabolism

Acronym

Relationship between 5-aminolevulinic acid and iron metabolism

Scientific Title

Relationship between 5-aminolevulinic acid and iron metabolism

Scientific Title:Acronym

Relationship between 5-aminolevulinic acid and iron metabolism

Region

Japan


Condition

Condition

Brain tumor

Classification by specialty

Anesthesiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will pursue iron metabolism after administration of 5-aminolevulinic acid (5-ALA).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum iron concentration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Other

Interventions/Control_1

Taking a blood sample

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

PDD-neurosurgery patients with consent for research

Key exclusion criteria

PDD-neurosurgery patients without consent for research

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Tohru
Middle name
Last name Shiratori

Organization

Ina Central Hospital

Division name

Anesthesiology

Zip code

396-8555

Address

1313-1 Koshiroukubo, Ina, Nagano

TEL

0265-72-3121

Email

ts_62475@inahp.jp


Public contact

Name of contact person

1st name Tohru
Middle name
Last name Shiratori

Organization

Ina Central Hospital

Division name

Anesthesiology

Zip code

396-8555

Address

1313-1 Koshiroukubo, Ina, Nagano

TEL

0265-72-3121

Homepage URL


Email

ts_62475@inahp.jp


Sponsor or person

Institute

Ina Central Hospital

Institute

Department

Personal name



Funding Source

Organization

Ina Central Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ina Central Hospital

Address

1313-1 Koshiroukubo, Ina, Nagano

Tel

0265-72-3121

Email

ts_62475@inahp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 07 Month 06 Day

Date of IRB

2023 Year 07 Month 06 Day

Anticipated trial start date

2023 Year 07 Month 13 Day

Last follow-up date

2030 Year 07 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 07 Month 13 Day

Last modified on

2026 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058836